A Phase 1, 6 Month Randomized, Double Blind, Placebo Controlled Study of the Effects of Asoprisnil on Ovarian Activity in Pre-Menopausal Subjects11/03/2005 - 11/02/2011 (PI)
TAP Pharmacutical Products
A Phase 3, Continuation Study to Evaluate the Long-Term Safety of Asoprisnil in Subjects with Uterine Leiomyomata04/07/2005 - 12/31/2009 (PI)
TAP Pharmacutical Products
A Phase III, 12 Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects with Uterine Leiomyomata03/11/2004 - 03/10/2006 (PI)
TAP Pharmacutical Products
Phase III, 12 Month, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Two Doses of J867 Versus Placebo in Subjects with Uterine Leiomyomata01/01/2002 - 12/31/2005 (PI)
TAP Pharmacutical Products